Online Study on the Impact of a Self-Help Tool for Social Anxiety

NCT07408102 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-04-20

No results posted yet for this study

Summary

The goal of this clinical trial is to understand which individuals benefit most from an internet-based cognitive behavioral intervention for social anxiety. Adults aged 18-65 will complete a self-guided online program designed to reduce anxiety symptoms. The investigators will use a combination of self-reported clinical information and data from computerized decision-making and cognitive tasks to predict changes in symptom scores from the intervention.

Conditions

  • Social Anxiety

Interventions

BEHAVIORAL

Internet-delivered self-help for social anxiety based on principles of cognitive behavioral therapy

Participants will be offered the use of a self-help tool, e-couch (https://ecouch.com.au), for 5 weeks. e-couch is an online, self-directed tool that provides interactive self-help and evidence-based information to help users understand and manage common mental health challenges including symptoms of depression and anxiety. The e-couch social anxiety program will be used in this study. It is structured like an interactive self-help book and participants can log back into at any time to learn and review skills. The e-couch social anxiety program includes a comprehensive information module, as well as self-help modules with interactive exercises and workbooks that teach evidence-based strategies. The content will cover topics such as cognitive restructuring and exposure, with an emphasis on learning strategies to reduce social anxiety.

Sponsors & Collaborators

  • Trustees of Princeton University

    lead OTHER

Principal Investigators

  • Yael Niv, PhD · Princeton University

  • Jamie C Chiu, PsyD · Princeton University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-12-31
Completion
2027-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07408102 on ClinicalTrials.gov